Complement Factor H 402H Variant and Reticular Macular Disease

Authors:
  • JMJoanna E. Merriam
    Joanna E. Merriam
  • MSMahsa A. Sohrab
    Mahsa A. Sohrab
  • NPNicole M. Pumariega
    Nicole M. Pumariega
  • GBGaetano Barile
    Gaetano Barile
  • ABAnna M. Blonska
    Anna M. Blonska
  • RHRaymond Haans
    Raymond Haans
  • DMDavid Madigan
    David Madigan
  • RARando Allikmets
    Rando Allikmets

Abstract
Two major genetic loci have been associated with an increased risk of age-related macular degeneration (AMD) through genome-wide scanning and candidate gene approaches. They are the chromosome 1q32 locus, which includes the complement factor H gene (CFH [Y402H, rs1061170]), where the common polymorphism Y402H is well established as a risk haplotype-tagging variant for AMD,1-4 and the age-related maculopathy susceptibility gene (ARMS2 [A69S, rs10490924]) on chromosome 10q26.5,6 Although the function of ARMS2 is unknown, it is significantly associated with end-stage AMD (ie, choroidal neovascularization [CNV] and geographic atrophy [GA]) and more weakly associated with early-stage AMD.5,7,8 In the case of CFH, whose role in regulating the alternative complement activation pathway is well known, a plausible scenario for disease pathogenesis is that the inflammation triggered by exposure to infectious agents or some other triggering event in genetically susceptible individuals leads to the sustained activation of complement, drusen formation, and, eventually, the development of AMD.9

This publication has 25 references indexed in Scilit: